| Advisers Back Merck Drug for Some Kidney Patients - Fox News |
|
|
Fox News Health advisers on Wednesday unanimously recommended use of Merck & Co's cholesterol-lowering drug Vytorin for preventing stroke and other heart problems in patients with chronic kidney disease, but only in those patients not yet on dialysis. ... FDA panel backs expanded use of Merck's Vytorin BusinessWeek FDA Advisory Committee Recommends Approval for Vytorin in Pre-Dialysis CKD ... Forbes FDA Advisory Committee Unanimously Recommends Approval of Merck's VYTORIN(R |